Evaluation of Quality of Life with the Chronic Obstructive Pulmonary Disease Assessment Test in Chronic Obstructive Pulmonary Disease and the Effect of Dyspnea on Disease-Specific Quality of Life in These Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The chronic obstructive pulmonary disease (COPD) assessment test (CAT) was recently introduced for use in assessing disease-specific quality of life and follow-up of patients with COPD. The purpose of this study was to evaluate the effect of the dyspnea on disease-specific quality of life detected by CAT score in patients with COPD. Materials and Methods: In this study, 90 stable patients with COPD as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria were included. The level of dyspnea was assessed with the Medical Research Council (MRC) dyspnea scale, and disease-specific quality of life was assessed with CAT score. Results: The mean±SD age was 68.5±10.9 (range 41-97) years. A significant relationship was established between CAT score, MRC dyspnea scale score and GOLD stage in patients with COPD. There was also a positive correlation between dyspnea scale scores and GOLD stage in the patients (p<0.001), as well as positive correlation between CAT score and dyspnea scale score (p<0.001). CAT score showed a significant correlation with hospitalization and exacerbations (p<0.05). Conclusion: Dyspnea is an important symptom that may impact quality of life in patients with COPD. CAT was shown to be a simple, fast and intelligible measurement of disease-specific quality of life, and was correlated with levels of dyspnea in patients with COPD.
Abstract
Purpose: The chronic obstructive pulmonary disease (COPD) assessment test (CAT) was recently introduced for use in assessing disease-specific quality of life and follow-up of patients with COPD. The purpose of this study was to evaluate the effect of the dyspnea on disease-specific quality of life detected by CAT score in patients with COPD. Materials and Methods: In this study, 90 stable patients with COPD as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria were included. The level of dyspnea was assessed with the Medical Research Council (MRC) dyspnea scale, and disease-specific quality of life was assessed with CAT score. Results: The mean±SD age was 68.5±10.9 (range 41-97) years. A significant relationship was established between CAT score, MRC dyspnea scale score and GOLD stage in patients with COPD. There was also a positive correlation between dyspnea scale scores and GOLD stage in the patients (p<0.001), as well as positive correlation between CAT score and dyspnea scale score (p<0.001). CAT score showed a significant correlation with hospitalization and exacerbations (p<0.05). Conclusion: Dyspnea is an important symptom that may impact quality of life in patients with COPD. CAT was shown to be a simple, fast and intelligible measurement of disease-specific quality of life, and was correlated with levels of dyspnea in patients with COPD.
참고문헌 (28)
- "Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline: Global Strategy for the Diagnosis, management and Prevention of Chronic Obstructive Pulmonary Disease" (2011)[URL]
- Oga T, "Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD", Respir Med, 100, pp.965~971 (2006)
- Bestall JC, "Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease", Thorax, 54, pp.581~586 (1999)
- Curtis JR, "Pulmonary rehabilitation in chronic respiratory insufficiency. 7. Health-related quality of life among patients with chronic obstructive pulmonary disease", Thorax, 49, pp.162~170 (1994)
- Curtis JR, "Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here?", Am J Respir Crit Care Med, 156(4), pp.1032~1039 (1997)
- Meguro M, "Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire", Chest, 132, pp.456~463 (2007)
- Wijkstra PJ, "Reliability and validity of the chronic respiratory questionnaire (CRQ)", Thorax, 49, pp.465~467 (1994)
- Jones PW, "Development and first validation of the COPD Assessment Test", Eur Respir J, 34, pp.648~654 (2009)
- Jones PW, "Properties of the COPD assessment test in a cross-sectional European study", Eur Respir J, 38, pp.29~35 (2011)
- Dodd JW, "The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study", Thorax, 66, pp.425~429 (2011)
- Al-Moamary MS, "The reliability of an Arabic translation of the chronic obstructive pulmonary disease assessment test", Saudi Med J, 32, pp.1028~1033 (2011)
- Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
- Ozalevli S, "The comparison of different dyspnoea scales in patients with COPD", J Eval Clin Pract, 12, pp.532~538 (2006)
- "CAT Turkish version" (2011)[URL]
- "COPD assessment test-healthcare professional user guide" (2009)[URL]
- Hajiro T, "Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 158, pp.1185~1189 (1998)
- Sahebjami H, "Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 161(3), pp.886~890 (2000)
- Mahler DA, "The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes", Chest, 85, pp.751~758 (1984)
- Taube C, "Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 162, pp.216~220 (2000)
- Mahler DA, "A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease", Am Rev Respir Dis, 145(2), pp.467~470 (1992)
- Chhabra SK, "Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease", Ann Thorac Med, 4, pp.128~132 (2009)
- Nishimura K, "Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD", Chest, 121, pp.1434~1440 (2002)
- Hu J, "Health-related quality of life in individuals with chronic obstructive pulmonary disease", Heart Lung, 34, pp.415~422 (2005)
- Hajiro T, "A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD", Chest, 116, pp.1632~1637 (1999)
- von Leupoldt A, "Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity, dyspnea, and quality of life in COPD", Lung, 186, pp.387~391 (2008)
- Miravitlles M, "Patient’s perception of exacerbations of COPD--the PERCEIVE study", Respir Med, 101, pp.453~460 (2007)
- Mahler DA, "Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD", Chest, 107, pp.1585~1589 (1995)
- Tsiligianni I, "Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations", Prim Care Respir J, 20, pp.257~268 (2011)